{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:19:55Z","timestamp":1793621995497,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"India Ministry of Science & Technology Department of Science and Technology","doi-asserted-by":"publisher","award":["SR\/FST\/LS-I\/2018\/173"],"award-info":[{"award-number":["SR\/FST\/LS-I\/2018\/173"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology, Government of West Bengal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["GrantECR\/2017\/001417"],"award-info":[{"award-number":["GrantECR\/2017\/001417"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["ECR\/2017\/001417"],"award-info":[{"award-number":["ECR\/2017\/001417"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020026","name":"Department of Higher Education, Government of West Bengal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jpet.2026.103810","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:25:10Z","timestamp":1769819110000},"page":"103810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selective serotonin reuptake inhibitor fluoxetine, reduces solid tumor burden and metastasis through activation of host antitumor immune response and modulation of tumor microenvironment"],"prefix":"10.1016","volume":"393","author":[{"given":"Krishna","family":"Mahanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayasree","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallabi","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debanjan","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik","family":"Pramanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dona","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maniprabha","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankar","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jpet.2026.103810_bib1","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.jpet.2026.103810_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.20892\/j.issn.2095-3941.2021.0036","article-title":"Cancer immunology and immunotherapy","volume":"18","author":"Ren","year":"2021","journal-title":"Cancer Biol Med"},{"issue":"3","key":"10.1016\/j.jpet.2026.103810_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41573-021-00368-1","article-title":"Immune targets for therapeutic development in depression: towards precision medicine","volume":"21","author":"Drevets","year":"2022","journal-title":"Nature Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.jpet.2026.103810_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41523-023-00508-3","article-title":"Immunotherapy in breast cancer: an overview of current strategies and perspectives","volume":"9","author":"Debien","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"8","key":"10.1016\/j.jpet.2026.103810_bib5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards targeting the breast cancer immune microenvironment","volume":"24","author":"Harris","year":"2024","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.jpet.2026.103810_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrclinonc.2015.215","article-title":"Clinical relevance of host immunity in breast cancer: from TILs to the clinic","volume":"13","author":"Savas","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jpet.2026.103810_bib7","first-page":"265","article-title":"Diagnosis, prognosis, and treatment of triple-negative breast cancer: a review","volume":"17","author":"Jie","year":"2025","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"7","key":"10.1016\/j.jpet.2026.103810_bib8","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"issue":"Suppl 2","key":"10.1016\/j.jpet.2026.103810_bib9","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.breast.2015.07.032","article-title":"Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer","volume":"24","author":"Stover","year":"2015","journal-title":"Breast"},{"issue":"22","key":"10.1016\/j.jpet.2026.103810_bib10","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.3390\/jcm14228243","article-title":"Recurrence patterns in breast cancer: a single-center retrospective analysis","volume":"14","author":"Oprean","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jpet.2026.103810_bib11","first-page":"523","article-title":"Triple-negative breast cancer on the rise: breakthroughs and beyond","volume":"17","author":"Agelidis","year":"2025","journal-title":"Breast cancer (Dove Medical Press)"},{"issue":"4","key":"10.1016\/j.jpet.2026.103810_bib12","article-title":"Antidepressants for the treatment of depression in people with cancer","volume":"4","author":"Ostuzzi","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpet.2026.103810_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101947","article-title":"Breast cancer vaccines: heeding the lessons of the past to guide a path forward","volume":"84","author":"Solinas","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.jpet.2026.103810_bib14","doi-asserted-by":"crossref","first-page":"e1156","DOI":"10.4088\/JCP.12f08054","article-title":"Breast cancer and antidepressant use","volume":"73","author":"Andrade","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.jpet.2026.103810_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/annonc\/mdx526","article-title":"The use of antidepressants in oncology: a review and practical tips for oncologists","volume":"29","author":"Grassi","year":"2018","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.jpet.2026.103810_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5306\/wjco.v6.i6.299","article-title":"Fluoxetine induces cytotoxic endoplasmic reticulum stress and autophagy in triple negative breast cancer","volume":"6","author":"Bowie","year":"2015","journal-title":"World J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jpet.2026.103810_bib17","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1177\/0300060519862469","article-title":"Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience","volume":"47","author":"Abdel Karim","year":"2019","journal-title":"J Int Med Res"},{"issue":"3","key":"10.1016\/j.jpet.2026.103810_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/neurolint13030038","article-title":"Selective serotonin reuptake inhibitors and adverse effects: a narrative review","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"key":"10.1016\/j.jpet.2026.103810_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110054","article-title":"Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model","volume":"126","author":"Hsu","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"10.1016\/j.jpet.2026.103810_bib20","doi-asserted-by":"crossref","first-page":"32101","DOI":"10.18632\/oncotarget.16646","article-title":"Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts","volume":"8","author":"Gwynne","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.jpet.2026.103810_bib21","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.7150\/jca.95592","article-title":"Fluoxetine as a potential therapeutic agent for inhibiting melanoma brain and lung metastasis: induction of apoptosis, G0\/G1 cell cycle arrest, and disruption of autophagy flux","volume":"15","author":"He","year":"2024","journal-title":"J Cancer"},{"issue":"9","key":"10.1016\/j.jpet.2026.103810_bib22","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.bcp.2008.01.015","article-title":"Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms","volume":"75","author":"Frick","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.103810_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0024-3205(02)02207-5","article-title":"Effects of fluoxetine on the activity of phagocytosis in stressed mice","volume":"72","author":"Freire-Garabal","year":"2002","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.103810_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbi.2008.06.010","article-title":"Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms","volume":"23","author":"Frick","year":"2009","journal-title":"Brain Behav Immun"},{"issue":"26","key":"10.1016\/j.jpet.2026.103810_bib25","doi-asserted-by":"crossref","first-page":"PL403","DOI":"10.1016\/S0024-3205(97)00329-9","article-title":"Effects of fluoxetine on the immunosuppressive response to stress in mice","volume":"60","author":"Freire-Garabal","year":"1997","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.jpet.2026.103810_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neulet.2005.11.042","article-title":"Effects of fluoxetine on cellular immune response in stressed mice","volume":"396","author":"N\u00fa\u00f1ez","year":"2006","journal-title":"Neurosci Lett"},{"issue":"14","key":"10.1016\/j.jpet.2026.103810_bib27","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1016\/j.cell.2025.04.032","article-title":"Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis","volume":"188","author":"Li","year":"2025","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jpet.2026.103810_bib28","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1021\/acsptsci.5c00199","article-title":"Selective serotonin reuptake inhibitor fluoxetine alters gene expression patterns of sarcoma and significantly reduces tumor load through modulation of the tumor microenvironment and restoration of the host antitumor immune system","volume":"8","author":"Mahanti","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.jpet.2026.103810_bib29","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3389\/fonc.2020.01195","article-title":"Multi-omics characterization of the 4T1 murine mammary gland tumor model","volume":"10","author":"Schr\u00f6rs","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jpet.2026.103810_bib30","article-title":"Mouse 4T1 breast tumor model","author":"Pulaski","year":"2001","journal-title":"Curr Protoc Immunol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103810_bib31","article-title":"Unraveling the roles of CD44\/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jpet.2026.103810_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2613.2007.00539.x","article-title":"The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci","volume":"88","author":"DuPr\u00e9","year":"2007","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jpet.2026.103810_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-4614-8244-4_10","article-title":"Syngeneic murine metastasis models: B16 melanoma","volume":"1070","author":"Giavazzi","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.jpet.2026.103810_bib34","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/ijc.34364","article-title":"DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patients","volume":"152","author":"Hey","year":"2023","journal-title":"Int J Cancer"},{"issue":"D1","key":"10.1016\/j.jpet.2026.103810_bib35","doi-asserted-by":"crossref","first-page":"D1257","DOI":"10.1093\/nar\/gkac833","article-title":"Comparative Toxicogenomics Database (CTD): update 2023","volume":"51","author":"Davis","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.103810_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/iep.12192","article-title":"Novel murine tumour models depend on strain and route of inoculation","volume":"97","author":"Fu","year":"2016","journal-title":"Int J Exp Pathol"},{"issue":"4","key":"10.1016\/j.jpet.2026.103810_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-016-4483-7","article-title":"Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation","volume":"234","author":"Ma","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.jpet.2026.103810_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"3","key":"10.1016\/j.jpet.2026.103810_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.jpet.2026.103810_bib41","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jleuko\/qiae013","article-title":"Alteration of functionality and differentiation directed by changing gene expression patterns in myeloid-derived suppressor cells (MDSCs) in tumor microenvironment and bone marrow through early to terminal phase of tumor progression","volume":"115","author":"Mahanti","year":"2024","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jpet.2026.103810_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120755","article-title":"Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment","volume":"305","author":"Pramanik","year":"2022","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.103810_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12672-024-01011-2","article-title":"Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity","volume":"15","author":"Xu","year":"2024","journal-title":"Discov Oncol"},{"issue":"6","key":"10.1016\/j.jpet.2026.103810_bib44","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1053\/j.gastro.2021.09.059","article-title":"Cyclooxygenases and prostaglandins in tumor immunology and microenvironment of gastrointestinal cancer","volume":"161","author":"Wang","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jpet.2026.103810_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12935-024-03525-9","article-title":"Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?","volume":"24","author":"Anvar","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"12","key":"10.1016\/j.jpet.2026.103810_bib46","first-page":"4799","article-title":"A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma","volume":"30","author":"Bobek","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jpet.2026.103810_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108631","article-title":"Orthotopic and metastatic tumour models in preclinical cancer research","volume":"257","author":"Stribbling","year":"2024","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jpet.2026.103810_bib48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1346-8138.2004.tb00676.x","article-title":"Histologic progression of B16 F10 metastatic melanoma in C57BL\/6 mice over a six week time period: distant metastases before local growth","volume":"31","author":"Eberting","year":"2004","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103810_bib49","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1038\/s41467-020-17249-7","article-title":"Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution","volume":"11","author":"Pommier","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jpet.2026.103810_bib50","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4132\/jptm.2019.02.03","article-title":"Prognostic role of claudin-1 immunohistochemistry in malignant solid tumors: a meta-analysis","volume":"53","author":"Pyo","year":"2019","journal-title":"J Pathol Transl Med"},{"issue":"23","key":"10.1016\/j.jpet.2026.103810_bib51","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1158\/0008-5472.CAN-21-3302","article-title":"E-Cadherin: context-dependent functions of a quintessential epithelial marker in metastasis","volume":"81","author":"Fang","year":"2021","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.jpet.2026.103810_bib52","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1073\/pnas.1918167117","article-title":"The functional activity of E-cadherin controls tumor cell metastasis at multiple steps","volume":"117","author":"Na","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.jpet.2026.103810_bib53","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.3390\/cancers13194985","article-title":"Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis","volume":"13","author":"Usman","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.jpet.2026.103810_bib54","doi-asserted-by":"crossref","first-page":"15966","DOI":"10.18632\/oncotarget.3862","article-title":"Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.jpet.2026.103810_bib55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41419-020-2651-5","article-title":"Snail promotes the generation of vascular endothelium by breast cancer cells","volume":"11","author":"Chang","year":"2020","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.jpet.2026.103810_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119705","article-title":"Snail transcription factors \u2013 characteristics, regulation and molecular targets relevant in vital cellular activities of ovarian cancer cells","volume":"1871","author":"Kielbik","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.103810_bib57","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s13193-024-01975-1","article-title":"Expression of EMT markers snail, slug, and twist and their association with known prognostic indicators of breast cancer","volume":"15","author":"Jacob","year":"2024","journal-title":"Indian J Surg Oncol"},{"issue":"6","key":"10.1016\/j.jpet.2026.103810_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100773","article-title":"Epithelial-mesenchymal transition in cancer: a historical overview","volume":"13","author":"Ribatti","year":"2020","journal-title":"Transl Oncol"},{"issue":"12","key":"10.1016\/j.jpet.2026.103810_bib59","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/jcm4121952","article-title":"Claudin 1 in breast cancer: new insights","volume":"4","author":"Zhou","year":"2015","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.jpet.2026.103810_bib60","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/ijc.29090","article-title":"The metastatic microenvironment: claudin-1 suppresses the malignant phenotype of melanoma brain metastasis","volume":"136","author":"Izraely","year":"2015","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.jpet.2026.103810_bib61","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050771","article-title":"The highly metastatic 4T1 breast carcinoma model possesses features of a hybrid epithelial\/mesenchymal phenotype","volume":"17","author":"Herndon","year":"2024","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jpet.2026.103810_bib62","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fonc.2020.00486","article-title":"Hypoxia-induced epithelial-mesenchymal transition in cancers: HIF-1\u03b1 and beyond","volume":"10","author":"Tam","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103810_bib63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103810_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","article-title":"Wnt\/\u03b2-catenin-driven EMT regulation in human cancers","volume":"81","author":"Xue","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.jpet.2026.103810_bib65","first-page":"1827","article-title":"\u03b2-Catenin nuclear translocation induced by HIF-1\u03b1 overexpression leads to the radioresistance of prostate cancer","volume":"52","author":"Luo","year":"2018","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.jpet.2026.103810_bib66","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ncb1534","article-title":"Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia","volume":"9","author":"Kaidi","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"17","key":"10.1016\/j.jpet.2026.103810_bib67","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3390\/cancers16172927","article-title":"Prognostic value of Fas\/Fas ligand expression on circulating tumor cells (CTCs) and immune cells in the peripheral blood of patients with metastatic breast cancer","volume":"16","author":"Papadaki","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jpet.2026.103810_bib68","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41598-020-80850-9","article-title":"Effect of SSRI exposure on the proliferation rate and glucose uptake in breast and ovary cancer cell lines","volume":"11","author":"Stapel","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jpet.2026.103810_bib69","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/13102818.2014.932136","article-title":"Study on anti-inflammatory and immunomodulatory effects of clomipramine in carrageenan- and lipopolysaccharide-induced rat models of inflammation","volume":"28","author":"Kostadinov","year":"2014","journal-title":"Biotechnol Biotechnol Equip"},{"key":"10.1016\/j.jpet.2026.103810_bib70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phrs.2015.11.021","article-title":"Immunomodulatory effects of fluoxetine: a new potential pharmacological action for a classic antidepressant drug?","volume":"109","author":"Di Rosso","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jpet.2026.103810_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/123026","article-title":"Fluoxetine dose and administration method differentially affect hippocampal plasticity in adult female rats","volume":"2014","author":"Pawluski","year":"2014","journal-title":"Neural Plast"},{"issue":"7","key":"10.1016\/j.jpet.2026.103810_bib72","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","article-title":"Effects of chronic fluoxetine in animal models of anxiety and depression","volume":"29","author":"Dulawa","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpet.2026.103810_bib73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2567.2011.03429.x","article-title":"The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis","volume":"133","author":"Steding","year":"2011","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.jpet.2026.103810_bib74","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.celrep.2016.11.062","article-title":"Myeloid-derived suppressor cells are controlled by regulatory T cells via TGF-\u03b2 during murine colitis","volume":"17","author":"Lee","year":"2016","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.jpet.2026.103810_bib75","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cellsig.2015.03.013","article-title":"Reactive oxygen species in the tumor niche triggers altered activation of macrophages and immunosuppression: role of fluoxetine","volume":"27","author":"Ghosh","year":"2015","journal-title":"Cell Signal"},{"key":"10.1016\/j.jpet.2026.103810_bib76","article-title":"Antitumor effect of fluoxetine on chronic stress-promoted lung cancer growth via suppressing kynurenine pathway and enhancing cellular immunity","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jpet.2026.103810_bib77","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/ph16050640","article-title":"Association between fluoxetine use and overall survival among patients with cancer treated with PD-1\/L1 immunotherapy","volume":"16","author":"Magagnoli","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.jpet.2026.103810_bib78","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.3390\/ijms25126314","article-title":"Beyond psychotropic: potential repurposing of fluoxetine toward cancer therapy","volume":"25","author":"Kadasah","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.103810_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119554","article-title":"Effect of antidepressants use on cancer morbidity and mortality: a propensity score-matched longitudinal cohort study","volume":"387","author":"Ma","year":"2025","journal-title":"J Affect Disord"},{"issue":"7","key":"10.1016\/j.jpet.2026.103810_bib80","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s43018-023-00570-7","article-title":"Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-\u03b3 is a major determinant of CD4+ CAR T-cell antitumor activity","volume":"4","author":"Boulch","year":"2023","journal-title":"Nat Cancer"},{"issue":"6","key":"10.1016\/j.jpet.2026.103810_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"Bhat","year":"2017","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.jpet.2026.103810_bib82","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.3892\/mmr.2015.3812","article-title":"Hypoxia-inducible factor-1\u03b1 and Wnt\/\u03b2-catenin signaling pathways promote the invasion of hypoxic gastric cancer cells","volume":"12","author":"Liu","year":"2015","journal-title":"Mol Med Rep"},{"issue":"40","key":"10.1016\/j.jpet.2026.103810_bib83","doi-asserted-by":"crossref","first-page":"33594","DOI":"10.1074\/jbc.M112.388298","article-title":"Coordinated action of hypoxia-inducible factor-1\u03b1 and \u03b2-catenin in androgen receptor signaling","volume":"287","author":"Mitani","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpet.2026.103810_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111345","article-title":"The potential roles of HIF-1\u03b1 in epithelial-mesenchymal transition and ferroptosis in tumor cells","volume":"122","author":"Shen","year":"2024","journal-title":"Cell Signal"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652600008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652600008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:18:35Z","timestamp":1776122315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652600008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S002235652600008X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103810","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective serotonin reuptake inhibitor fluoxetine, reduces solid tumor burden and metastasis through activation of host antitumor immune response and modulation of tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103810"}}